FamGenix

What FamGenix does

FamGenix, Inc. (legal entity FamHis, Inc., dba FamGenix; headquartered in Fargo, ND with prior offices in Boynton Beach and Delray Beach, FL) builds a cloud-based family health history and pedigree platform that helps clinicians and patients assess hereditary disease risk. The platform is deployed on AWS with regional data residency in the US, Canada, the EU/UK, and Australia/Asia-Pacific, and is HIPAA- and GDPR-compliant (SOC 2 Type 1 completed April 2026, Type 2 in progress). Core products include the Provider Portal (a pedigree chart maker with built-in medical ontology — HPO, OMIM, CHV, NCI, HGNC — and automated guideline-based identification of patients meeting NCCN/ACMG/ASBrS referral criteria), the Patient App (a free mobile/web family health history questionnaire in English, Spanish, French, German, and Dutch with the FamShare family data-sharing feature), the Clinicians Platform (enterprise tier with EHR integration and API), a White Label/Embedded integration offer, and a Risk Server API that sub-licenses validated cancer and cardiovascular risk models (BOADICEA v6, Tyrer-Cuzick v8, BayesMendel, Gail, Claus, QRISK3). The company sells through a hybrid GTM: direct enterprise field sales to healthcare systems and clinical genetics teams, OEM/embedded and white-label licensing to EHR and clinical platforms, and a freemium direct-to-consumer channel via the free patient app on iOS and Android. Revenue is generated through individual subscriptions ($500/year per license), tiered enterprise contracts, and add-on fees for advanced risk models, custom questionnaires, EHR integration, and API access. Distribution is supported by partnerships with My Gene Counsel (March 2025) and Spesana (December 2023), and customer logos include City of Hope, UCSF, Boston Children's, Sharp HealthCare, Allina Health, UnityPoint Health, MercyOne, NHS Liverpool, and Cork University Hospital.

Name

FamGenix

Legal name

FamHis, Inc.

Website

https://famgenix.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

FamGenix is a cloud-based family health history and pedigree platform that helps clinicians, genetic counselors, and patients assess hereditary disease risk, serving healthcare providers, EHR partners, and individual patients across the US, Canada, the EU/UK, and Australia.

Ownership category

akta.pro rank

Headquarters

HQ city

Boynton Beach

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations, Others

Revenue model

1. Individual Subscription License: Annual subscription license at $500/year for single-user access with unlimited pedigrees. Includes basic features with additional fees for premium add-ons like advanced risk models and patient questionnaires.
2. Premium Enterprise License: Tiered pricing model for multi-user enterprise deployments with full feature access including multi-user access, EHR integration, API access, and custom branding. Additional fees apply for custom features.
3. Risk Model Licensing (Add-on): Additional fee add-ons for individual risk assessment models: BOADICEA (+$100), Tyrer-Cuzick v8 (+$100), BayesMendel (+$100). Gail and Claus models included in base Individual license.
4. Patient Questionnaire Add-on: Additional fee for standard or custom patient questionnaires and surveys. Standard questionnaires available as additional fee on Individual tier; custom data fields, questionnaires and surveys available as additional fee on both tiers.
5. White-Label/Embedded Integration Licensing: Embedding FamGenix pedigree and risk assessment functionality into existing clinical systems with flexible licensing based on specific needs. Includes SSO integration and maintains patient data control within existing systems.
6. API Risk Model Sub-licensing: Send family history data to FamGenix risk server via API to calculate and return results for display in customer's existing system. Enables risk model usage without full platform deployment.
7. Free Patient App: Free mobile and web app for patients to record and maintain family health history, assess hereditary disease risk, and share with family members. Revenue generated from healthcare provider licensing of the platform that connects to patient data.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

FamGenix provides a cloud-based family health history platform combining a pedigree drawing tool, integrated cancer and cardiovascular genetic risk assessment models, and a patient-facing mobile/web app. The platform enables clinicians, genetic counselors, and health systems to capture family health history, generate pedigrees, run multiple risk models simultaneously, and automatically identify patients meeting NCCN/ACMG referral criteria. It is offered through Individual subscriptions, Premium enterprise licenses, white-label/embedded OEM integrations, and a Risk Server API for existing clinical systems.

Product overview

FamGenix offers a unified family health history platform with three core components: the Provider Portal (a comprehensive pedigree drawing and genetic risk assessment tool for clinicians), the Patient App (a mobile/web application for family health history collection available in English, Spanish, French, German, and Dutch), and the Clinicians Platform (an enterprise solution combining all tools with EHR integration and API access). The platform integrates multiple cancer and cardiovascular risk assessment models (BOADICEA, Tyrer-Cuzick, BayesMendel, Gail, Claus, QRISK3) that run simultaneously to calculate 5-year, 10-year, and lifetime hereditary disease risk. The system automatically identifies patients meeting NCCN/ACMG clinical guidelines for genetic counseling referral. White-label and API options enable integration into existing clinical systems and custom branded deployments.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Patients meeting referral criteria are automatically identified based on NCCN/ACMG/ASBrS guidelines, displaying specific reasons criteria was met
• +3 more outcomes

Named customers16 records

Segments3 records

Ideal customer profiles3 records

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Partnerships

Three partnerships are on record, tiered core.

• My Gene CounselcoreStrategic or Co-development Partner · 18 March 2025Strategic partnership announced March 18, 2025 to provide healthcare centers with comprehensive digital genetic risk assessment and education toolkit. Combined platform facilitates risk assessment for hereditary cancer, cardiovascular disease, kidney disease, lymphoma, reproductive disorders, rare diseases, and other genetic conditions. Includes pre-test and post-test genetic education and ongoing dynamic updates specific to genetic test results.
• SpesanacoreStrategic or Co-development Partner · 18 December 2023Strategic partnership announced December 18, 2023 to advance precision medicine and integrate FamGenix hereditary risk screening with Spesana's clinical workflow ecosystem. FamGenix pedigree and hereditary risk assessment solutions planned to be seamlessly integrated with Spesana's solution, providing comprehensive tools for clinicians at point of care. Both companies committed to making family health histories part of every patient's electronic health record.
• Amazon Web Services (AWS)coreTechnology or Integration · 1 January 2020Cloud infrastructure provider using AWS with dedicated regional servers in US, Canada, EU, UK, and Australia. AWS core infrastructure designed to meet most stringent security requirements for healthcare, banks, and military. Enables FamGenix to achieve and monitor HIPAA and GDPR compliance. Most extensive global network of regions ensures consistent security and compliance standards across all deployments.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Customer concentration

• LinkedInlinkedin.com/company/famgenix
• Xx.com/famgenix

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds4 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FamGenix